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Plasmacytoid DCs (pDCs) are a rare population 
of circulating cells specialized in the production 
of large amounts of type I IFNs (IFN-/) in 
response to viral infections (Cella et al., 1999; 
Siegal et al., 1999). This ability is linked to 
their unique intracellular expression of toll-like 
receptor (TLR) 7 and TLR9 (Kadowaki et al., 
2001), which recognize single-stranded (ss)   
viral RNA and DNA transported into endosomal 
compartments by the virus infecting the cell 
(Hemmi et al., 2000, 2002; Diebold et al., 2004; 
Heil et al., 2004). IFN-/ produced by pDCs 
was shown to be critical in inhibiting viral   
replication but also to contribute to the in-
duction and expansion of an antiviral immune 
response by activating memory T cells, B cells, 
and NK cells (Theofilopoulos et al., 2005; 
Gilliet et al., 2008). Under steady-state condi-
tions, pDCs are present in the blood stream and 
secondary lymphoid organs but are normally 
absent from most peripheral tissues including   
the skin (Wollenberg et al., 2002; Gilliet et al., 
2004). pDCs can, however, infiltrate the skin 
infected by viruses including varicella zoster 
virus (Gerlini et al., 2006), human papillo-
mavirus (Vanbervliet et al., 2003), and herpes 
simplex virus (Donaghy et al., 2009). These skin-
infiltrating pDCs were found to produce IFN-
/, which is consistent with the ability of 
viruses to infect pDCs and deliver their nucleic 
acid cargo into intracellular TLR7/9 compart-
ments of pDCs.
Surprisingly, large numbers of pDCs have 
also been found in the skin of patients with psori-
asis (Wollenberg et al., 2002; Gilliet et al., 2004; 
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Plasmacytoid dendritic cells (pDCs) are specialized type I interferon (IFN-/)–producing 
cells that express intracellular toll-like receptor (TLR) 7 and TLR9 and recognize viral nucleic 
acids in the context of infections. We show that pDCs also have the ability to sense host-
derived nucleic acids released in common skin wounds. pDCs were found to rapidly infiltrate 
both murine and human skin wounds and to transiently produce type I IFNs via TLR7- and 
TLR9-dependent recognition of nucleic acids. This process was critical for the induction of 
early inflammatory responses and reepithelization of injured skin. Cathelicidin peptides, 
which facilitate immune recognition of released nucleic acids by promoting their access to 
intracellular TLR compartments, were rapidly induced in skin wounds and were sufficient but 
not necessary to stimulate pDC activation and type I IFN production. These data uncover  
a new role of pDCs in sensing tissue damage and promoting wound repair at skin surfaces.
© 2010 Gregorio et al.  This article is distributed under the terms of an Attri-
bution–Noncommercial–Share  Alike–No  Mirror  Sites  license  for  the  first  six 
months after the publication date (see http://www.rupress.org/terms). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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In this paper, we found that skin injury 
induces an early and short-lived infiltration of 
pDCs into skin wounds. These pDCs were 
activated to produce IFN-/ through TLR7 
and TLR9, indicating that they recognize 
self-nucleic acids released by damaged cells 
in skin wounds. Cathelicidin gene expression 
closely paralleled pDC activation and catheli-
cidin peptides were found to be sufficient to 
induce IFN-/ production by pDC in the 
skin. However, cathelicidins were not required 
to induce IFN-/ expression, suggesting a redundancy of this 
pathway for pDC activation in injured skin. Depletion of pDCs 
or inhibition of IFN-/ receptor signaling significantly im-
paired the acute inflammatory cytokine response and delayed 
reepithelization of skin wounds. These data uncover a novel role 
of pDCs in sensing nucleic acids in wounded skin and demon-
strate their involvement in the acute inflammatory response and 
wound healing through their production of IFN-/.
RESULTS
Skin injury induces a rapid infiltration of pDCs
To determine whether injury of normal skin induces infiltra-
tion and activation of pDCs, we adopted a mechanical skin 
injury model based on tape stripping of shaved murine skin 
(Sano et al., 2005; Jin et al., 2009). This procedure mechani-
cally removes the upper epidermal layers and injures the basal 
layer, leading to an acute inflammatory response and reepi-
thelization of the skin (Wojcik et al., 2000). We found that 
tape stripping induced a robust dermal influx of leukocytes 
reaching a peak between 24 and 48 h after skin injury (Fig. 1, 
A and B). Analysis of single cell suspensions revealed that, 
24 h after skin injury, the majority of cells infiltrating the 
dermis were Gr-1+CD11b+ neutrophils (mean, 37.8%; range, 
Nestle et al., 2005), a chronic inflammatory disease of the 
skin mediated by autoimmune T cells. In psoriatic skin, pDCs 
are  chronically  activated  to  produce  IFN-/,  a  process 
which triggers the activation and expansion of autoimmune 
T cells leading to the epidermal hyperproliferation and the 
formation of psoriasis (Nestle et al., 2005). We have recently 
found that pDC activation in psoriatic skin is driven by the 
human  cathelicidin  antimicrobial  peptide  known  as  LL37 
(Lande et al., 2007). LL37 was found to convert otherwise 
inert extracellular host-derived (self) nucleic acids, into a po-
tent trigger of pDC activation by forming a complex with the 
self-RNA and self-DNA and by transporting them into intra-
cellular TLR7 and TLR9 compartments (Lande et al., 2007; 
Ganguly et al., 2009). The cathelicidin peptide is usually not 
expressed in healthy skin but was found to be continuously 
overexpressed by keratinocytes of psoriatic skin, providing an 
explanation for the chronic activation of pDCs in psoriasis 
(Lande et al., 2007). Interestingly, the expression of cathe-
licidin peptides can be transiently induced in keratinocytes 
by common skin injury (Dorschner et al., 2001; Schauber   
et al., 2007). However, whether skin injury is associated 
with pDC infiltration and activation to produce IFN-/ 
is not known.
Figure 1.  Rapid infiltration of pDCs into injured 
skin. (A) Representative image of shaved murine back 
skin 24 h after tape stripping. (B) Dermal cell suspen-
sions isolated from skin at various times after injury and 
viable cells were counted. The mean number of cells ± 
SEM per cm2 of injured skin is given and represent data 
from five mice over a 3-d time course. (C) The percent-
age of pDCs (B220+PDCA-1+), neutrophils (Gr-1+CD11b+),  
and T cells (CD3+) in dermal single cell suspensions  
isolated from injured skin was measured by flow  
cytometry. Data are the mean ± SEM of five mice per 
each time point. (D) Flow cytometry plot of pDC, neu-
trophils, and T cells in injured skin over a 3-d time 
course. Data are representative of five mice. The per-
centage of each population is shown in the plots.  
(E) Flow cytometry for CD11c, IA/IE, and Siglec H surface 
expression on B220+PDCA-1+ pDC 24 h after skin injury. 
(F) Representative immunohistochemical staining for 
Siglec H in injured skin collected 24 h after tape strip-
ping. Bars: (main image) 50 µm; (inset) 10 µm. Data in 
A–F are representative of two independent experiments.JEM VOL. 207, December 20, 2010 
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are the main source of IFN-/ in injured skin (Fig. 1 C and 
Fig. 2 A). In contrast, the expression of the inflammatory   
cytokines IL-6 and TNF showed a distinct time course. IL-6 
mRNA expression reached a peak 6 h after injury (Fig. 2 A), 
which is consistent with injured keratinocytes as an early 
source of this cytokine (Sehgal, 1990). TNF was induced 24 h 
after injury but its expression was sustained for up to 72 h 
(Fig. 2 A), suggesting that cell types other than pDCs are a 
major source of this cytokine. To confirm the role of pDCs 
as principal producers of IFN-/ in injured skin, we de-
pleted pDCs by treating mice with antibodies recognizing 
BST-2, a transmembrane protein specifically expressed on 
resting mouse pDCs (Blasius et al., 2006). Two injections of 
these antibodies at 48 and 24 h before skin injury efficiently 
depleted pDCs (Fig. S2), as previously reported (Krug et al., 
2004; Yoneyama et al., 2005; Blasius et al., 2006; Kuwajima 
et al., 2006). pDC depletion completely inhibited the accu-
mulation of pDC in injured skin (not depicted) and abro-
gated the induction of IFN-2 (Fig. 2 B) and IFN- (not 
depicted) expression at 24 h, confirming that pDCs are the 
principal source of IFN-/ in injured skin. Interestingly, 
pDC depletion partially affected the expression of IL-6, 
whereas the expression of TNF was not affected at 24 h after 
injury. Because the infiltration of pDCs into injured skin is 
paralleled by the infiltration of neutrophils, we next sought to 
determine the role of neutrophils in the expression of these 
cytokines. Neutrophil depletion using a Ly6G-specific anti-
body did not show significant effect on the expression of 
IFN-/ and IL-6 (Fig. 2 B) but significantly decreased the 
expression of TNF (Fig. 2 B), which is consistent with neu-
trophils being a main early source of this cytokine (Dubravec 
et al., 1990; Hübner et al., 1996). These data demonstrate 
that skin injury induces early infiltration of pDCs and their 
local activation to produce IFN-/.
pDCs sense self-nucleic acid in injured skin
pDCs  produce  IFN-/  upon  recognition  of  ssRNA  or 
DNA via intracellular TLR7 and TLR9, respec-
tively (Gilliet et al., 2008). To determine the in-
volvement of TLRs in pDC activation to produce 
IFN-/ in injured skin, we used mice deficient 
in the adaptor molecule MyD88, which lack the 
ability to signal through many TLRs including 
31–42.9%; Fig. 1 C). Interestingly, a large number of pDCs, 
detected as PDCA1+B220+ cells, also infiltrated the dermis 24 h   
after injury (mean, 14.4%; range, 3.7–28%; Fig. 1, C and D). 
The pDC identity was confirmed by showing that these cells   
coexpressed CD11c, MHC class II molecules, and the pDC-
specific marker Siglec-H (Zhang et al., 2006; Fig. 1 E) and 
lacked common lineage markers CD3, CD19, and CD11b 
(not  depicted).  Furthermore,  immunohistochemistry  for 
Siglec-H  showed  that  these  cells  had  typical  lymphocytic 
morphology (Fig. 1 F). The accumulation of pDCs and 
neutrophils in skin wounds was rapid and transient, as they 
accumulated at 24 h but returned to preinjury levels after 
48 h. In contrast, CD3+ T cells were constitutively present 
in uninjured skin, and increased in number at a later time 
point (48 h after injury; Fig. 1, C and D). Conventional DCs 
in the dermal compartment of injured skin were detected as 
CD11c+PDCA1 cells, and their number did not increase 
but, rather, showed a tendency toward a decrease (Fig. S1), 
potentially reflecting their activation and migration to lymph 
nodes as previously reported (Holzmann et al., 2004). Thus, 
skin injury induces a rapid and robust infiltration of pDCs 
that parallels the early wound infiltration by neutrophils.
Skin injury induces a transient activation of pDCs  
to produce type I IFNs
Because pDCs are specialized producers of IFN-/, pro-
ducing 100–1,000× more than any other cell type (Siegal 
et al., 1999), we sought to investigate whether pDCs infiltrating 
injured skin are activated to produce IFN-/. First, we iso-
lated total skin from mice at different time points after injury 
and performed gene expression analysis. mRNA expression 
levels of both IFN-2 (Fig. 2 A) and IFN- (not depicted) 
was undetectable in normal skin before injury but rapidly in-
duced by skin injury. Both IFN-2 and IFN- (unpublished 
data) mRNA expression levels reached a peak 24 h after in-
jury and rapidly declined thereafter. This expression profile 
closely paralleled the presence of pDCs, suggesting that pDCs 
Figure 2.  pDCs are transiently activated to produce type I 
IFNs in injured skin. (A) Time course analysis of IFN-, IL-6, 
and TNF mRNA tissue expression in injured skin. The data are 
given as fold induction over time 0 and represent the mean ± 
SEM of five mice per time point. (B) Relative IFN-, IL-6, and 
TNF mRNA tissue expression of uninjured skin or injured skin 
collected 24 h after tape stripping of pDC-depleted, neutro-
phil-depleted, or control IgG-treated mice. Data represent the 
mean ± SEM of five mice per group. *, P = 0.001; **, P = 0.02; 
***, P < 0.001, unpaired Student’s t test. Data in A and B are 
representative of at least two independent experiments.2924 Skin wound healing is driven by pDCs and TLR7/9 | Gregorio et al.
TLR7 and TLR9 (Takeda and Akira, 2004). In contrast to 
control mice, MyD88-deficient mice failed to up-regulate 
expression of IFN-2 and IFN- mRNA in injured skin 
(Fig. 3 A), demonstrating the involvement of TLRs in pDC 
activation in wounded skin. To specifically demonstrate that 
pDCs recognize nucleic acids in injured skin, we used the 
oligonucleotide IRS 954 which selectively inhibits TLR7 
and TLR9 signaling in pDCs (Barrat et al., 2005). Injection 
of IRS 954 before tape stripping completely abrogated ex-
pression of both IFN-2 and IFN- mRNA (Fig. 3 B).   
Because TLR7 and TLR9 were reported to have opposing 
inflammatory roles in a mouse model of lupus (Christensen   
et al., 2006), we sought to determine the specific contributions 
of TLR7 and TLR9 in the induction of IFN-/ in injured 
skin. Expression of both IFN-2 and IFN mRNA was 
found to be profoundly abrogated in TLR7-deficient mice 
(Fig. S3). Blocking of TLR9 by the specific oligonucleotide 
IRS 869 also resulted in a reduction of IFN-2 mRNA ex-
pression in injured skin (Fig. S3), a finding which was con-
firmed in TLR9-deficient mice by our companion paper (see 
Guiducci et. al. in this issue). These data indicate that pDC 
activation to produce IFN-/ in injured skin is dependent on 
both TLR7 and TLR9. Interestingly, similar to the pDC de-
pletion data, deficiency of MyD88 and TLR7 or inhibition of 
TLR9 did not result in a reduction of the neutrophil-dependent 
TNF expression (Fig. S3 and Fig. S4), suggesting that TLR7 
and TLR9 activation preferentially occurs in pDCs (Fig. S3 
and Fig. S4). Because mechanical skin injury is largely sterile, 
Figure 3.  pDCs sense nucleic acid in injured skin. (A) Relative IFN- 
and IFN- mRNA tissue expression in injured skin collected 24 h after 
tape stripping of MyD88/ or control mice. Data represent the mean ± 
SEM of five mice per group. *, P = 0.01; **, P = 0.02, unpaired Student’s t 
test. (B) Relative IFN- and IFN- mRNA tissue expression in injured skin 
(24 h) of mice pretreated with 0, 1, 10, or 100 µg of TLR7 and TLR9 inhibi-
tor IRS 954. Data represent the mean ± SEM of three mice per group.  
*, P = 0.002; **, P = 0.02; ***, P = 0.01, unpaired Student’s t test. Data in  
A and B are representative of at least two independent experiments.
Figure 4.  Cathelicidin peptides are sufficient but not necessary to 
induce pDC activation to produce type I IFNs in injured skin. (A) Time 
course analysis of cathelicidin mRNA tissue expression in injured skin. The 
data are given as fold induction over time 0 and represent the mean ± SEM 
of four mice per time point. (B) IFN- produced by purified splenic pDC after 
overnight stimulation with DNA alone, CRAMP alone, scrambled (sc) CRAMP 
alone, CRAMP plus DNA, or scCRAMP plus DNA. Data are representative of 
two independent experiments. Error bars represent the SEM of triplicate 
wells. *, P = 0.001. (C) Flow cytometry time course analysis of pDCs 
(B220+PDCA-1+) in dermal single cell suspensions derived from skin injected 
with either saline or CRAMP. The percentage of each population is shown in 
the plots. (D) Relative IFN- and IFN- mRNA tissue expression in the skin 
injected with either saline, CRAMP, or scCRAMP and collected after 24 h. 
Data represent the mean ± SEM of five mice per group. *, P = 0.02; **, P = 0.1, 
unpaired Student’s t test. (E) Relative IFN- and IFN- mRNA tissue  
expression in uninjured skin or injured skin collected 24 h after tape strip-
ping of Cramp/ or control wild-type mice. Data represent the mean ± SEM 
of five mice per group. n.s., not significant, unpaired Student’s t test. Data in 
A and C–E are representative of at least two independent experiments.JEM VOL. 207, December 20, 2010 
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TLR9 in the presence of cathelicidin peptides (Lande et al., 
2007; Ganguly et al., 2009). We therefore sought to deter-
mine whether cathelicidins are induced in our skin injury 
model. The expression of cathelicidin mRNA in murine skin 
was undetectable before injury but was found to be rapidly 
induced upon tape stripping, reaching a peak at 24 h and de-
clining thereafter (Fig. 4 A). This time course closely paral-
leled  the  infiltration  of  pDCs  into  injured  skin  and  their 
these findings indicate that pDCs recognize host-derived self-
nucleic acids, most likely released by keratinocytes or other 
cells damaged in the context of the skin injury.
Cathelicidins are sufficient but not necessary to trigger pDC 
activation in skin
Host-derived nucleic acids released by damaged cells are nor-
mally inert but can be converted into triggers of TLR7 and 
Figure 5.  pDC and type I IFNs participate in the inflammatory response and reepithelialization of skin wound healing. (A) Relative IL-23p19, 
IL-12p35, IL-17A, IL-22, and IFN- mRNA tissue expression of uninjured skin or injured skin collected 24 h after tape stripping of either pDC-depleted or 
control IgG-treated mice. Data represent the mean ± SEM of five mice per group. *, P = 0.03; **, P = 0.05; ***, P = 0.04, unpaired Student’s t test. (B) Rep-
resentative time course of Keratin 6 (K6) expression in injured skin measured by immunofluorescence. Bar, 10 µm. (C) Percentage of K6 expression in in-
jured skin in pDC-depleted and control IgG treated mice. Data represent the mean ± SEM of five mice per group. *, P = 0.01; **, P = 0.05, unpaired 
Student’s t test. (D) Time course of wound closure after full-thickness injury of the skin pDC-depleted or IgG-treated mice (right). Data represent the 
mean ± SEM of at least three mice per group. *, P = 0.02; **, P < 0.001; ***, P = 0.005, unpaired Student’s t test. (E) Percentage of K6 expression in injured 
skin in IFNAR/ or control mice. Data represent the mean ± SEM of three mice per group for each time point. *, P = 0.002; **, P < 0.001, unpaired Stu-
dent’s t test. (F) Relative TNF, IL-6, IL-23p19, IL-12p35, IL-17A, IL-22, and IFN- mRNA tissue expression of uninjured skin or injured skin collected 24 h 
after tape stripping of IFNAR/ or control mice. Data represent the mean ± SEM of five mice per group: *, P = 0.003; **, P = 0.04, unpaired Student’s t 
test. Data in A–F are representative of at least two independent experiments.2926 Skin wound healing is driven by pDCs and TLR7/9 | Gregorio et al.
activation to produce IFN-/, suggesting a potential role of 
cathelicidins in breaking innate tolerance to self-nucleic acids 
injured skin. To investigate this possibility, we first stimulated 
purified pDCs with DNA alone, the mouse cathelicidin peptide 
(called CRAMP) alone, or DNA mixed with CRAMP. As a 
control, we also used a scrambled form of CRAMP alone or 
mixed  with  DNA.  We  found  that  only  DNA  mixed  with 
CRAMP induced IFN- production in pDCs (Fig. 4 B). To test   
whether CRAMP would also break innate tolerance to nucleic 
acids and activate pDCs in vivo, we injected CRAMP, the 
scrambled peptide, or saline into mouse skin. We found that 
CRAMP, but not the scrambled peptide or saline injection, 
induced a rapid and transient infiltration of pDCs and the ex-
pression of IFN-/ (Fig. 4, C and D). These findings indi-
cate that CRAMP is sufficient to break innate tolerance to 
induce activation of pDCs to produce IFN-/ in the skin 
in vivo. To determine whether CRAMP is necessary for 
pDC activation to injured skin, we tape stripped the skin of 
cathelicidin-deficient mice (Nizet et al., 2001) and analyzed 
gene expression for IFN-/. Surprisingly, we found that 
IFN- and IFN- produced by pDCs were still induced in 
injured skin even in the absence of cathelicidins (Fig. 4 E). 
Thus, cathelicidins are sufficient but not necessary to break 
innate tolerance to nucleic acids and induce IFN-/ pro-
duction by pDCs in injured skin.
pDCs and type I IFNs promote inflammatory responses  
and wound healing in injured skin
Because pDCs are potent stimulators of immune responses 
through their production of IFN-/, we next sought to in-
vestigate the role of pDCs in the induction of inflammatory 
responses in injured skin. We found that, along with IL-6 
and TNF (Fig. 2 A), skin injury induced a rapid expression of 
the DC-derived cytokines IL-12 and IL-23, Th1 cytokine 
IFN-, and Th17 cytokines IL-17 and IL-22 (Fig. 5 A), but 
not IL-4 or IL-10 (not depicted), reaching a peak between   
24 and 48 h after injury. pDC depletion, which reduced the 
expression of IL-6 in injured skin (Fig. 2 A), was also found 
to decrease the expression of IL-12 and IL-23 (Fig. 5 A).   
Intriguingly, pDC depletion was found to profoundly inhibit 
the induction of IL-17 and IL-22 without affecting the ex-
pression of IFN- (Fig. 5 A). These findings demonstrate that 
skin-infiltrating pDCs play and important role in the induc-
tion of inflammatory immune responses in injured skin, in 
particular the induction of IL-6 and Th17 cytokines.
Because the inflammatory process is directly linked to the 
wound-healing response, we next sought to determine whether 
pDCs also play a role in the reepithelization of tape-stripped 
skin. Keratin 6 (K6), expressed by early differentiating and 
proliferating keratinocytes but not by fully differentiated   
keratinocytes, was used as a marker to quantify reepithelization 
Figure 6.  Human skin injury induces rapid infiltration of pDC and 
their activation to produce IFN-. (A) Representative immunohisto-
chemical staining of human skin for the pDC-specific marker BDCA2 re-
veals absence of pDCs in normal skin before injury (top left), the rapid 
infiltration of pDC in injured skin by tape stripping (top right and bottom 
left), or by treatment with SLS (bottom right). Bar, 10 µm. The data are 
representative of at least five independent healthy individuals (B) Quanti-
fication of BDCA2-positive pDC numbers in human skin before and 24 h 
after tape stripping of five independent healthy individuals (left), and 
relative IFN- mRNA tissue expression in healthy human skin before and 
24 h after tape stripping (right). Each symbol represents an independent 
donor. *, P = 0.05; **, P = 0.03, unpaired Student’s t test. (C) Quantification 
of BDCA2-positive pDC numbers in human skin before and 24 h after 
chemical injury with SLS of five independent healthy individuals (left). 
Relative IFN- mRNA tissue expression in human skin before and 24 h 
after chemical injury with SLS of at least seven independent healthy indi-
viduals (right). Each symbol represents the independent individual. *, P = 0.04; 
**, P < 0.001, unpaired Student’s t test.
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inflammatory responses and reepithelization of skin wounds. 
Although pDCs have been classically considered a specialized 
immune cell type in sensing viral infection and initiating anti-
viral immunity, our study now identifies an additional im-
portant physiological function of these cells in sensing tissue 
damage and initiating tissue repair at epithelial surfaces.
The ability of pDCs to sense host-derived nucleic acids 
has been recently uncovered in psoriasis (Lande et al., 2007; 
Ganguly et al., 2009). Keratinocytes of psoriatic skin lesions 
are continuously activated to produce cathelicidin peptides, a 
family of cationic antimicrobial peptides with the ability to 
break innate tolerance to extracellular nucleic acids released 
by dying cells. This occurs by forming complexes with the 
released self-DNA and self-RNA and by promoting their 
transport into intracellular compartments containing TLR7 
and TLR9, leading to chronic pDC activation and IFN-/ 
production (Lande et al., 2007; Ganguly et al., 2009). In this 
study, we show that in contrast to psoriatic skin, the expres-
sion of cathelicidin peptides in injured skin is short lived and 
associated with the transient IFN-/ expression. We also 
show that injection of cathelicidin peptides into healthy skin 
is sufficient to trigger pDC infiltration and activation, sug-
gesting a potential role for these peptides in pDC activation 
in the skin. However, we demonstrate that cathelicidin peptides 
produced in injured skin are not required for pDC activation, 
suggesting redundancy of this pathway and the presence of 
additional factors that control the immunogenicity of extra-
cellular self-nucleic acids. It is unlikely that this process is driven 
by autoantibodies and the formation of immune complexes, 
as we did not find an increase in anti-nuclear antibodies after 
skin injury (unpublished data). Potential factors that drive this 
process are HMGB1 (Tian et al., 2007), heat shock proteins 
(Okuya et al., 2010), and other cationic antimicrobial peptides 
(unpublished data), as they are all expressed in damaged skin 
and they have the ability to form self-nucleic acid–containing 
complexes that activate pDCs.
pDC migration to the skin has been attributed to the ef-
fect of chemerin, an agonist for CMKLR1 (chemokine-like 
receptor 1) which is specifically expressed by pDCs (Vermi 
et al., 2003; Zabel et al., 2005; Albanesi et al., 2009). Chemerin 
is constitutively expressed in healthy skin by endothelial cells 
and fibroblasts as an inactive propeptide that requires activation 
through C-terminal cleavage by serine proteases. It is possible 
that during skin injury the release of proteases by damaged 
keratinocytes allows the formation of the active chemerin that 
recruits pDCs to the injury site. In addition, skin injury in-
duces the expression of CXCR3 ligands (unpublished data), a 
set of chemokines which are typically induced in structural 
cells of the skin as a result of IFN-/ expression and which 
have been shown to promote recruitment pDCs into sites of 
their activation (Vanbervliet et al., 2003).
We demonstrate that skin-infiltrating pDCs are impor-
tant for the induction of early inflammatory responses that 
promote reepithelization of skin wounds. pDCs signifi-
cantly contribute to the expression of IL-6, an inflammatory   
cytokine which indirectly stimulates reepithelization of skin 
of skin wounds (Wojcik et al., 2000). In normal mice, K6-
positive keratinocytes appeared 24 h after injury and repopu-
lated the entire injured skin surface within 72 h (Fig. 5 B).   
In pDC-depleted mice, K6-positive keratinocytes appeared only 
around 72 h (Fig. 5 C) and complete reepithelization lagged 
behind control mice by 3 d (not depicted). These data indicate 
that the infiltration of pDCs in skin wounds plays a key role 
in promoting early wound reepithelization. To confirm these 
data, we adopted another skin injury model in which a full-
thickness skin defect is placed by a 3-mm punch biopsy and 
the wound closure is measured over time. Similarly, pDC- 
depleted  mice  showed  a  significant  delay  in  wound  closure 
when compared with control mice (Fig. 5 D). To determine the 
role of pDC-derived IFN-/ in this process, we used IFN-
/ receptor-deficient mice and repeated similar experiments. 
Like pDC-depleted mice, IFN-/ receptor-deficient mice 
showed a significant delay in wound reepithelization (Fig. 5 E) 
and displayed a profound deficiency in IL-6, IL-17, and IL-22 
expression levels in injured skin, without affecting the expres-
sion of IFN- (Fig. 5 F). A similar deficiency of IL-6, IL-17, 
and IL-22 expression was observed in MyD88-deficient mice 
(Fig. S5). These data suggest that the ability of pDCs to trigger 
early inflammatory responses and promote wound repair is 
related to their nucleic acid–mediated TLR activation and 
production of IFN-/.
Injury of human skin induces pDC infiltration and expression 
of type I IFNs
To determine whether pDCs also infiltrate and sense human 
skin wounds, we performed skin biopsies in healthy human 
volunteers before and 24 h after tape stripping. Immunohisto-
chemistry for BDCA2, a specific marker for human pDCs, re-
vealed that large numbers of pDCs infiltrate human skin 24 h 
after mechanical injury (Fig. 6, A and B). We also found a sig-
nificant induction of IFN- mRNA expression in injured skin 
(Fig. 6 B), suggesting that pDCs are activated to produce IFN- 
similar to our finding in the murine models. We also con-
firmed these data in another model of skin injury induced by 
sodium lauryl sulfate (SLS) treatment, which induces a chemi-
cal disruption of the epidermal barrier by perturbing the lipid 
bilayer structure in the stratum corneum, leading to damages to 
the basal keratinocytes (Welzel et al., 1998). Like mechanical-
induced skin injury, this chemical-induced skin injury–induced 
rapid  pDC  infiltration  and  significant  induction  of  IFN- 
mRNA expression in injured skin (Fig. 6, A and C).
DISCUSSION
Our study identifies a new physiological function of pDCs. 
We show that pDCs, which are normally absent from healthy 
skin, rapidly infiltrate common skin wounds with a surpris-
ingly rapid kinetics, paralleling the infiltration of neutrophils. 
We also find that these pDCs become activated to produce 
IFN-/ through endosomal TLR7 and TLR9, suggesting 
that they recognize nucleic acids released in the skin wounds. 
Finally, we demonstrate that these pDCs and their activation 
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Reagents. The synthetic mouse cathelicidin peptide CRAMP (GLLRK-
GGEKIGEKLKKIGQKIKNFFQKLVPQPEQ)  and  the  corresponding 
scrambled control (LLGQNGKFKIREPPIQKVKGIQEKEFGLKQKLKG) 
were obtained from AnaSpec. For in vivo experiments, 200 µg of the pep-
tides were injected into the dermis of the upper dorsum of shaven and depil-
ated mice. For in vitro pDC stimulation, 30 µM of the peptides were used. 
The TLR 7/9 inhibitor IRS 954 was a gift from F. Barrat (Dynavax Tech-
nologies, Berkely, CA). The TLR9 inhibitor IRS 869 (5-TCCTGGA-
GGGGTTGT-3, phosphorothioate oligodeoxynucleotide) was purchased 
from Integrated DNA Technologies. For inhibition of TLR9 or TLR7 plus 
TLR9 in vivo, intradermal administration of IRS 869 or IRS 954 was in-
jected 24 and 4 h before the skin injury.
Mechanical injury of mouse skin. Mice backs were shaven and depilated 
(Veet; Reckitt Benckiser) immediately before injury. Mechanical injury was 
then applied by tape stripping, using 20 strokes of transparent tape (3M; 
Scotch) across the back. For full-thickness injury, mice dorsal skin was 
shaven and cleaned with 70% ethanol, and a 3-mm punch biopsy (Acuderm) 
was applied to remove skin (care was taken to ensure excision was restricted 
to a depth of the fascia layer). Calipers were used to monitor wound closure 
over a 14-d period.
Depletion experiments. PDC depletion was performed using a combina-
tion of two anti-BST antibodies (PDCA1; clone JF05-1C2.4.1; Miltenyi 
Biotec) and mAb 927 (provided by M. Colonna, Washington University 
School of Medicine, St. Louis, MO; Blasius et al., 2006). 0.5 mg of each   
antibody was injected, intraperitoneally, 48 and 24 h before injury. Rat IgG 
antibodies were injected into control mice. Depletion of pDCs was moni-
tored in the spleen by flow cytometry and was found to be most efficient 
when the combination of the antibodies was used. Neutrophil depletion was 
conducted using an anti-Ly6G–specific antibody (clone 1A8; BioXell). 1 mg 
anti-Ly6G or whole rat IgG was injected, intraperitoneally, into mice at 24 
and 4 h before injury.
Mechanical and chemical injury of human skin. Mechanical injury of 
human skin was induced by application of 10 strokes of cellophane tape 
across healthy skin of seven human volunteers. Biopsies were taken before 
(uninjured) and 24 h after (injured) tape stripping. The specimen was snap 
frozen and stored at 80°C before immunohistochemical and gene expres-
sion analysis was performed.
Chemical injury of human skin was induced by treatment of healthy skin 
of human volunteers with the chemical irritant SLS (Merck) at 1% in water as 
described previously (Meller et al., 2007). In brief, SLS was applied in large 
Finn Chambers to the skin on the back of the patients before biopsies were 
taken. Specimens were immediately snap frozen and stored at 80°C before 
immunohistochemical and gene expression analysis was performed. All   
human studies were performed at the Skin and Allergy Hospital at Helsinki 
University Central Hospital (Helsinki, Finland) and approved by the local 
ethics committee (Helsinki-Uusimaa Hospital District Ethics Committee).
Generation and analysis of dermal single cell suspensions. Injured 
skin was excised, minced, and digested with 1 mg/ml Dispase (Sigma- 
Aldrich) for 1 h at 37°C and the epidermis was manually removed with for-
ceps. The dermis was removed to a clean culture plate and incubated with   
1 mg/ml collagenase (Invitrogen) for 2 h to generate a single cell suspension. 
Leukocytes were counted using trypan blue exclusion. Cells were treated for 
20 min with anti-CD16/CD32 to block nonspecific binding, followed by 
the addition of the following antibodies at 10 µg/ml final concentration for 
20 min: anti–PDCA-1 FITC (Miltenyi Biotec), anti–Siglec-H-FITC (eBio-
science), anti–CD11c-PE, anti–B220-APC, anti–IA/IE-PE, anti–CD11b-
FITC, anti–Gr-1-PerCp-Cy5.5, and anti–CD3e-APC (all BD). Cells were 
washed twice and acquired on a FACSCalibur (BD) and analyzed using 
FlowJo software (Tree Star, Inc.).
Immunohistochemistry and immunofluorescence. Mouse skin tissue 
was excised, embedded in OCT (Tissue-Tek), and frozen immediately on 
wounds (Gallucci et al., 2004). pDCs also affect the produc-
tion of Th17 cytokines, as the induction of IL-17 and IL-22 
is abrogated in pDC-depleted mice. This is consistent with 
recent studies showing that pDCs can drive the differentia-
tion of IL-17– and IL-22–producing T cells (Duhen et al., 
2009; Isaksson et al., 2009; Yu et al., 2010) and that IL-6 is 
implicated in this process (Duhen et al., 2009). IL-22 appears 
to be particularly important in epidermal regeneration, as this 
cytokine directly promotes keratinocyte migration and pro-
liferation (Boniface et al., 2005; Zheng et al., 2007; Eyerich   
et al., 2009). Surprisingly, mice deficient in IFN-/ receptors 
display a similar inhibition in IL-6 and Th17 cytokine induc-
tion with delayed reepithelization of skin wounds. Because 
IFN- and IFN- are potent stimulators of immune responses 
but do not exert a direct activity on keratinocytes (van der Fits 
et al., 2004), these findings suggest that IFN-/ in skin 
wounds promotes epidermal regeneration and wound repair 
through the induction of Th17-biased inflammatory responses. 
The exact mechanism that links IFN-/ production to pDC-
mediated Th17 responses is still unclear. However, there is ad-
ditional evidence that IFN-/ produced by pDCs drives 
Th17 responses and epidermal proliferation in a therapeutic 
model of skin treated with the TLR7 agonist imiquimod (van 
der Fits et al., 2009). Furthermore, IFN-/ produced by 
pDCs triggers psoriasis (Nestle et al., 2005), a disease character-
ized by large numbers of pathogenic Th17 cells which trigger 
epidermal hyperproliferation (Zaba et al., 2007).
The new pathway for the induction of inflammation and 
wound healing described in this paper appears to comple-
ment the recent finding that skin injury triggers keratinocyte 
activation via TLR3 (Lai et al., 2009), a TLR which recog-
nizes double-stranded (ds) RNA and signals independently of 
MyD88. A likely scenario is that skin injury induces TLR3 
activation of keratinocytes with the production of factors that 
control the recruitment of pDCs and the ability of pDCs to 
sense nucleic acids. Future studies will have to test this possi-
bility and further elucidate the interplays between keratino-
cytes and pDCs in the wound-healing response.
In conclusion, our study identifies a role of pDCs in rec-
ognizing nucleic acids released in injured skin and promoting 
early inflammatory responses and reepithelization of the 
wounds. These findings provide a paradigm shift in under-
standing the function of pDCs from the classical view of a 
specialized cell type in the recognition of viral infections to 
important sensors of tissue damage at epithelial surfaces.
MATERIALS AND METHODS
Mice. All animal experiments were approved by the Institutional Animal 
Care and Use Committee of the University of Texas M.D. Anderson Cancer 
Center. Wild-type BALB/cJ, C57BL/6, or 129SV/J mice and TLR7/ 
(B6.129S1-Tlr7tm1Flv/J) mice were purchased from The Jackson Labora-
tory. MyD88/ mice were provided by S. Akira (Osaka University, Osaka, 
Japan; Adachi et al., 1998) and IFNAR/ mice (Müller et al., 1994) were 
provided by W. Overwijk (University of Texas M.D. Anderson Cancer 
Center, Houston, TX). Cramp/ mice were from the laboratory of R.L. 
Gallo (Nizet et al., 2001). All animal experiments were conducted on 6–14-wk- 
old mice. Animals were maintained and bred in pathogen-free facilities.JEM VOL. 207, December 20, 2010 
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dry ice. 8-µM frozen sections were cut and stained with anti-Siglec H (3H3 
clone; Kamogawa and Arai, personal communication) followed by horse-
radish peroxidase–labeled goat anti–rat IgG and a color development step with 
aminoethylcarbazole. For K6 staining, frozen sections were stained with a 
purified rabbit anti–mouse keratin 6 antibody (Covance) and subsequently 
stained with Alexa Fluor 546–labeled goat anti rabbit IgG (H+L; Invitro-
gen). For detection of pDCs in human skin tissue we used an anti-BDCA2 
antibody (Miltenyi Biotec) according to the previously described protocol 
(Lande et al., 2007).
Real-time PCR analysis. All excised tissue was immediately saturated in 
RNAlater (Applied Biosystems) and stored at 20°C until RNA was iso-
lated. RNA was isolated using a tissue homogenizer (Thermo Fisher Scien-
tific) along with a commercial kit (RiboPure; Applied Biosystems), followed 
by RNA clean up with an additional kit (RNAqueous; Applied Biosystems). 
All isolated RNA had an A260/A280 value of ≥1.7. 2 µg RNA was used to 
generate cDNA using a commercial kit (High Capacity cDNA; Applied Bi-
osystems). 40 ng cDNA was used for each individual gene expression analysis 
using Taqman-based amplification on an ABI 7500 Fast system using the de-
fault Standard protocol. Mouse Taqman probes used were: Gapdh, Ifna2, 
Ifnb, Cramp, Il6, Tnf, Il23p19, Il12p35, Il12p40, Il22, Il17a, and Ifng. 
Human Taqman probes used were Gapdh and Ifna2.
pDC  isolation  and  in  vitro  stimulation.  pDCs  were  isolated  from 
spleens of 6–12-wk-old female BALB/cJ mice using the pDC Isolation kit II 
(Miltenyi Biotec) with a purity of >90%. 50,000 cells were cultured over-
night in RPMI-based media (10% FCS, 50 µM -mercaptoethanol, pen/
strep, glutamine, sodium pyruvate, and Hepes). The supernatants were used 
to determine IFN- protein secretion using a commercial Elisa kit (PBL). As 
a source of DNA, we used synthetic phosphodiesteric CpG-containing oli-
gonucleotides hybridized to its complementary strand to mimick natural 
mammalian DNA fragments. 0.3 µM dsDNA was mixed with 30 µM cathe-
licidin peptides in a volume of 20 µl for 30 min at room temperature.
Online supplemental material. Fig. S1 shows the kinetics of mDCs in 
the skin after skin injury. Fig. S2 shows the efficiency of pDC depletion in 
the spleen over a 5-d period using BST-specific monoclonal antibodies. Fig. S3 
shows the role of TLR7 and TLR9 in the expression of type I IFN, IL-6, 
and TNF induced by skin injury. Fig. S4 shows the role of MyD88 and 
TLR7/9 in the induction of IL-6 and TNF in injured skin. Fig. S5 shows 
the role of MyD88 in the induction of T cell–derived IL-17A, IL-22, and 
IFN- in injured skin. Online supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20101102/DC1.
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